TOIIW
The Oncology Institute IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-602.09
Beta
0.20
52W High
$0.27
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-12.10%
Forward P/E
—
PEG Ratio
—
About The Oncology Institute Inc
The Oncology Institute Inc. (TOIIW) is a leading provider of specialized cancer care, focusing on high-quality, accessible treatment through its broad network of outpatient facilities. With a strong emphasis on innovative therapies and a patient-centric model, the company strives to improve clinical outcomes while enhancing the overall patient experience. As the demand for specialized oncology services continues to rise, The Oncology Institute is well-positioned for strategic growth and market expansion, which is expected to drive significant long-term value for institutional investors.
Fundamentals
| Revenue (TTM) | $502.73M |
| Gross Profit (TTM) | $76.44M |
| EBITDA | $-29.14M |
| Operating Margin | -4.87% |
| Return on Equity | -4132.00% |
| Return on Assets | -13.40% |
| Revenue/Share (TTM) | $5.44 |
| Book Value | $-0.16 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.60% |
| Shares Outstanding | 0 |
| Float | $64.74M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026